Publications Database

McDougle C. J. , Kem D. , Posey D. J. (2002)

Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

41(8), pp. 921-927

Read Abstract (New Window)

Ming X. , Walters A. S. (2009)

Autism spectrum disorders, attention deficit/hyperactivity disorder, and sleep disorders.

Current Opinion in Pulmonary Medicine

15(6), pp. 5785-84.

Read Abstract (New Window)

Mukaddes N. M. , Abali O. , Gurkan K. (2004)

Short-term efficacy and safety of risperidone in young children with autistic disorder (AD).

World Journal of Bilogical Psychiatry

5(4), pp. 211-214

Read Abstract (New Window)

Nagaraj R. , Singhi P. , Malhi P. (2006)

Risperidone in children with autism: randomized, placebo-controlled, double-blind study.

Journal of Child Neurology

21(6), pp. 450-455

Read Abstract (New Window)

Nicolson R. , Awad G. A. , Sloman L. (1998)

An open trial of risperidone in young autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

37(4), pp. 372-376

Read Abstract (New Window)

Pandina G. J. et al. (2006)

Risperidone improves behavioral symptoms in children with autism. in a randomized, double-blind, placebo-controlled trial.

Journal of Autism and Developmental Disorders

37(2), pp.367-373.

Read Abstract (New Window)

Posey D. J. et al. (2001)

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 267-277

Read Abstract (New Window)

Potenza M. et al. (1999)

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Journal of Clinical Psychopharmacology

19(1), pp. 37-4.

Read Abstract (New Window)

Schreier H. (1998)

Risperidone for young children with mood disorders and aggressive behavior.

Journal of Child and Adolescent Psychopharmacology

8(1), pp. 49-59

Read Abstract (New Window)

Scott L. , Dhillon S. (2008)

Spotlight on risperidone in irritability associated with autistic disorder in children and adolescents.

CNS Drugs

22(3), pp. 259-262

Read Abstract (New Window)

Shea S. et al. (2004)

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Pediatrics

114(5), e. 634-641

Read Abstract (New Window) Read Full (New Window)

Stachnik J. M. , Nunn-Thompson C. (2007)

Use of atypical antipsychotics in the treatment of autistic disorder.

Annals of Pharmacotherapy

41(4), pp. 626-634

Read Abstract (New Window)

Stavrakaki C. , Antochi R. , Emery P. C. (2004)

Olanzapine in the treatment of pervasive developmental disorders: a case series analysis.

Journal of Psychiatry and Neuroscience

29(1), pp. 57-60

Read Full (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2004)

Case report: aripiprazole for maladaptive behavior in pervasive developmental disorder.

Journal of Child and Adolescent Psychopharmacology

14(3), pp. 455-463

Read Abstract (New Window)

Stores G. (1996)

Practitioner review: assessment and treatment of sleep disorders in children and adolescents.

Journal of Child Psychology and Psychiatry and Allied Disciplines

37(8), pp. 907-925

Read Abstract (New Window)

Troost P. et al. (2006)

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.

Journal of Child and Adolescent Psychopharmacology

pp. 611-619

Read Abstract (New Window)

Troost P. et al. (2005)

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Journal of the American Academy of Child and Adolescent Psychiatry

44(11), pp. 1137-1144

Read Abstract (New Window)